Clinical Trial Update: Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol [Phase 1]

View source ↗

Summary

Open-label Phase 1 bioequivalence study of naloxegol in healthy volunteers for opioid-induced constipation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Naloxegol (naloxegol)

Snippet

Sponsor: AstraZeneca | Conditions: Opioid Induced Constipation | Phase 1 | Status: COMPLETED